# Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

> **NCT01608269** · PHASE4 · COMPLETED · sponsor: **Therapeutic Concepts** · enrollment: 30 (estimated)

## Conditions studied

- HiV1- Positive

## Interventions

- **DRUG:** Abacavir/Lamivudine

## Key facts

- **NCT ID:** NCT01608269
- **Lead sponsor:** Therapeutic Concepts
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01608269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01608269, "Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01608269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*